Although beyond the scope of the present study, future studies could determine more precisely the mechanisms by which C3aR/C5aR1 agonism influences breast cancer growth, including potential effects on the function of myeloid and lymphocyte cell populations, and the ability to regulate tumor angiogenesis. The gene discussed is C3AR1; the disease is breast carcinoma.